Cargando…

Exploring the “Insight Paradox” in Treatment-Resistant Schizophrenia: Correlations Between Dimensions of Insight and Depressive Symptoms in Patients Receiving Clozapine

OBJECTIVE: There remains a lack of clarity as to the possible cross talk of insight into illness and depressive symptoms in treatment-resistant schizophrenia. We therefore set our primary aim to evaluate relationship between insight dimensions and depressive symptoms in patients with treatment-resis...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dönmezler, Süleyman, İskender, Gizem, Fıstıkcı, Nurhan, Altunkaynak, Yavuz, Ulusoy, Sevinç, Berkol, Tonguç Demir
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AVES 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10334689/ https://www.ncbi.nlm.nih.gov/pubmed/37440902 http://dx.doi.org/10.5152/alphapsychiatry.2023.221030

Ejemplares similares

Commentary: “Exploring the “Insight Paradox” in Treatment Resistant Schizophrenia: Correlations Between Dimensions of Insight and Depressive Symptoms in Patients Receiving Clozapine”
por: Stoyanov, Drozdstoy
Publicado: (2023)

A study of the relationship between serum uric acid levels and pain in patients with migraine
por: Altunkaynak, Yavuz, et al.
Publicado: (2023)

Insight in Schizophrenia: Relationship to Positive, Negative and Neurocognitive Dimensions
por: Joseph, Boban, et al.
Publicado: (2015)

The Association Between the Duration of Breastfeeding in Infancy and Adult Psychopathology: A Cross-Sectional Study in Turkey
por: Aytaç, Hasan Mervan, et al.
Publicado: (2022)

Comparison of Clinical Features of Bipolar Disorder Patients with and without Psychiatric Comorbidity
por: Berkol, Tonguc Demir, et al.
Publicado: (2021)

Exploring the clinical characteristics and etiological factors of comorbid major depressive disorder and social anxiety disorder
por: Berkol, Tonguc Demir, et al.
Publicado: (2023)

USE OF CLOZAPINE IN CHILDHOOD SCHIZOPHRENIA
por: Srinivasan, T.N., et al.
Publicado: (1997)

Recent Insights into the Paradoxical Effect of Echinocandins
por: Wagener, Johannes, et al.
Publicado: (2017)

Effectiveness of clozapine in treatment-resistant schizophrenia
por: Raguraman, Janakiraman, et al.
Publicado: (2005)

Clozapine: Improvement of Negative Symptoms of Schizophrenia
por: Khan, Afaque H, et al.
Publicado: (2017)

Clozapine Response in Schizophrenia and Hematological Changes
por: Blackman, Graham, et al.
Publicado: (2021)

Clozapine discontinuation withdrawal symptoms in schizophrenia
por: Blackman, Graham, et al.
Publicado: (2021)

Management of patients with Clozapine Resistant Schizophrenia
por: Rajendran*, Nithya Ragavi, et al.
Publicado: (2022)

Two Patients with Schizophrenia Treated with Clozapine Developed Neutropenia After Receiving a COVID-19 Vaccine
por: Tomita, Tetsu, et al.
Publicado: (2022)

Difference between treatment-resistant schizophrenia and clozapine-resistant schizophrenia
por: Tseng, Ping-Tao, et al.
Publicado: (2022)

The Relationship between Symptom Severity and Low Vitamin D Levels in Patients with Schizophrenia
por: Doğan Bulut, Süheyla, et al.
Publicado: (2016)

Clozapine- and non-clozapine-associated neutropenia in patients with schizophrenia: a retrospective cohort study
por: Johannsen, Claas-Frederik, et al.
Publicado: (2022)

Clozapine Reverses Dysfunction of Glutamatergic Neurons Derived From Clozapine-Responsive Schizophrenia Patients
por: Hribkova, Hana, et al.
Publicado: (2022)

A False Case of Clozapine-Resistant Schizophrenia
por: Maia-de-Oliveira, J. P., et al.
Publicado: (2010)

REFRACTORY SCHIZOPHRENIA, CLOZAPINE AND EPILEPSY : MANAGEMENT STRATEGIES
por: Guha, Prathama, et al.
Publicado: (1998)

AN OPEN STUDY OF CLOZAPINE IN THE TREATMENT OF RESISTANT SCHIZOPHRENIA
por: Desai, Neena, et al.
Publicado: (1999)

Combination of ECT and clozapine in drug-resistant schizophrenia
por: Kurian, S., et al.
Publicado: (2005)

Homocysteine Levels in Patients with Schizophrenia on Clozapine Monotherapy
por: Wysokiński, Adam, et al.
Publicado: (2013)

Glutamatergic Neurometabolites in Clozapine-Responsive and -Resistant Schizophrenia
por: Goldstein, Meghan Elizabeth, et al.
Publicado: (2015)

Clozapine Pharmacogenetic Studies in Schizophrenia: Efficacy and Agranulocytosis
por: Numata, Shusuke, et al.
Publicado: (2018)

Clozapine resistant schizophrenia: Newer avenues of management
por: Chakrabarti, Subho
Publicado: (2021)

Cariprazine — an Alternative Treatment for Clozapine-resistant Schizophrenia?
por: Montgomery, Adam, et al.
Publicado: (2023)

Evaluation of the Effectiveness of an Aerobic Exercise Program and the Personality Characteristics of Patients with Fibromyalgia Syndrome: A Pilot Study
por: Vural, Meltem, et al.
Publicado: (2014)

In the aftermath of clozapine discontinuation: comparative effectiveness and safety of antipsychotics in patients with schizophrenia who discontinue clozapine
por: Luykx, Jurjen J., et al.
Publicado: (2020)

INSIGHT, PSYCHOPATHOLOGY & SCHIZOPHRENIA
por: Armstrongh, K.P. Lincoln, et al.
Publicado: (2002)

INSIGHT AND PSYCHOPATHOLOGY IN SCHIZOPHRENIA
por: Tharyan, Anna, et al.
Publicado: (2000)

Genomic insights into schizophrenia
por: Owen, Michael J.
Publicado: (2023)

Adaptation to metabolic stress: Insights into a paradoxical Q
por: Reid, Michael A., et al.
Publicado: (2013)

Lipids and atrial fibrillation: New insights into a paradox
por: Sagris, Dimitrios, et al.
Publicado: (2022)

Slower clozapine titration is associated with delayed onset of clozapine-induced fever among Japanese patients with schizophrenia
por: Kikuchi, Yuki, et al.
Publicado: (2023)

Chemotherapy for Hodgkin's lymphoma in a patient receiving clozapine for treatment-resistant schizophrenia: use of the Mental Capacity Act 2005
por: Chamberlain, Florence Elizabeth, et al.
Publicado: (2015)

Effectiveness of Electroconvulsive Therapy Augmentation on Clozapine-Resistant Schizophrenia
por: Kim, Hye Sung, et al.
Publicado: (2017)

41. RECONSIDERING THE EVIDENCE FOR CLOZAPINE FOR TREATMENT REFRACTORY SCHIZOPHRENIA
por: MacCabe, James
Publicado: (2018)

Combination of Electroconvulsive Therapy and Clozapine in Treatment-Resistant Schizophrenia
por: Kim, Jung Hyun, et al.
Publicado: (2018)

Treatment of Hypochondriasis in Two Schizophrenia Patients Using Clozapine
por: Tundo, Antonio, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_1tlhmndrrv05pc8nk10kki99nb